These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19825845)
1. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Takahashi K; Adachi K; Yoshizaki K; Kunimoto S; Kalaria RN; Watanabe A Hum Mol Genet; 2010 Jan; 19(1):79-89. PubMed ID: 19825845 [TBL] [Abstract][Full Text] [Related]
2. Transendocytosis is impaired in CADASIL-mutant NOTCH3. Watanabe-Hosomi A; Watanabe Y; Tanaka M; Nakagawa M; Mizuno T Exp Neurol; 2012 Jan; 233(1):303-11. PubMed ID: 22079830 [TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3. Meng H; Zhang X; Yu G; Lee SJ; Chen YE; Prudovsky I; Wang MM PLoS One; 2012; 7(9):e44964. PubMed ID: 23028706 [TBL] [Abstract][Full Text] [Related]
4. Potent inhibitors of amyloid β fibrillization, 4,5-dianilinophthalimide and staurosporine aglycone, enhance degradation of preformed aggregates of mutant Notch3. Takahashi K; Adachi K; Kunimoto S; Wakita H; Takeda K; Watanabe A Biochem Biophys Res Commun; 2010 Nov; 402(1):54-8. PubMed ID: 20888320 [TBL] [Abstract][Full Text] [Related]
5. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Duering M; Karpinska A; Rosner S; Hopfner F; Zechmeister M; Peters N; Kremmer E; Haffner C; Giese A; Dichgans M; Opherk C Hum Mol Genet; 2011 Aug; 20(16):3256-65. PubMed ID: 21628316 [TBL] [Abstract][Full Text] [Related]
6. The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo. Monet M; Domenga V; Lemaire B; Souilhol C; Langa F; Babinet C; Gridley T; Tournier-Lasserve E; Cohen-Tannoudji M; Joutel A Hum Mol Genet; 2007 Apr; 16(8):982-92. PubMed ID: 17331978 [TBL] [Abstract][Full Text] [Related]
8. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Peters N; Opherk C; Zacherle S; Capell A; Gempel P; Dichgans M Exp Cell Res; 2004 Oct; 299(2):454-64. PubMed ID: 15350543 [TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-oxide alleviates the severe aggregation and ER stress caused by G98R alphaA-crystallin. Gong B; Zhang LY; Pang CP; Lam DS; Yam GH Mol Vis; 2009 Dec; 15():2829-40. PubMed ID: 20029648 [TBL] [Abstract][Full Text] [Related]
10. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: two novel mutations in the NOTCH3 gene in Chinese. Lee YC; Yang AH; Liu HC; Wong WJ; Lu YC; Chang MH; Soong BW J Neurol Sci; 2006 Jul; 246(1-2):111-5. PubMed ID: 16580020 [TBL] [Abstract][Full Text] [Related]
11. Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells. Hanemaaijer ES; Panahi M; Swaddiwudhipong N; Tikka S; Winblad B; Viitanen M; Piras A; Behbahani H Eur J Cell Biol; 2018 Nov; 97(8):557-567. PubMed ID: 30392756 [TBL] [Abstract][Full Text] [Related]
12. Two novel mutations of the NOTCH3 gene in Korean patients with CADASIL. Kim Y; Kim JS; Kim G; No YJ; Yoo HW Mutat Res; 2006 Jan; 593(1-2):116-20. PubMed ID: 16256149 [TBL] [Abstract][Full Text] [Related]
13. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ruchoux MM; Domenga V; Brulin P; Maciazek J; Limol S; Tournier-Lasserve E; Joutel A Am J Pathol; 2003 Jan; 162(1):329-42. PubMed ID: 12507916 [TBL] [Abstract][Full Text] [Related]
14. Nephroangiosclerosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: is NOTCH3 mutation the common culprit? Guerrot D; François A; Boffa JJ; Boulos N; Hanoy M; Legallicier B; Triquenot-Bagan A; Guyant-Marechal L; Laquerriere A; Freguin-Bouilland C; Ronco P; Godin M Am J Kidney Dis; 2008 Aug; 52(2):340-5. PubMed ID: 18572291 [TBL] [Abstract][Full Text] [Related]
15. Lunatic fringe promotes the aggregation of CADASIL NOTCH3 mutant proteins. Suzuki S; Hiura S; Mashiko T; Matsumoto T; Itoh M Biochem Biophys Res Commun; 2021 Jun; 557():302-308. PubMed ID: 33894418 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Pantoni L; Pescini F; Nannucci S; Sarti C; Bianchi S; Dotti MT; Federico A; Inzitari D Neurology; 2010 Jan; 74(1):57-63. PubMed ID: 20038773 [TBL] [Abstract][Full Text] [Related]
17. Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models. Di Maio G; Formichi P; Radi E; Bianchi S; Onnis A; Tarquini E; Leoncini L; Federico A J Cell Physiol; 2012 Apr; 227(4):1771-5. PubMed ID: 21702048 [TBL] [Abstract][Full Text] [Related]
18. [Study of the familiar form of vascular dementia (CADASIL)]. Takahashi K; Yoshizaki K Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Jun; 27(3):141-5. PubMed ID: 17633526 [TBL] [Abstract][Full Text] [Related]
19. CADASIL-causing mutations do not alter Notch3 receptor processing and activation. Low WC; Santa Y; Takahashi K; Tabira T; Kalaria RN Neuroreport; 2006 Jul; 17(10):945-9. PubMed ID: 16791082 [TBL] [Abstract][Full Text] [Related]
20. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)]. Ueda M; Nakaguma R; Ando Y Rinsho Byori; 2009 Mar; 57(3):242-51. PubMed ID: 19363995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]